1Chardot C, Carton M, Spire-Bendelac N, et al. Epidemiology of biliary atresia in France: a national study 1986-96 [ J]. J Hepa- to1,1999,31 (6) :1006-1013.
2Hsiao CH, Chang MH, Chela HL, et al. Universal screening for biliary atresia using an infant stool color card in Taiwan [ J ]. Hepatology ,2008,47 (4) : 1233-1240.
3Fischler B ,Haglund B, Hjem A. A population based study onthe incidence and possible pre- and perinatal risk factors ofextrahe- patic biliary atresia[ J]. J Pediatr,2002,141 (2) :217-222.
4Jimenez-Rivera C, Jolin-Dahel KS, Fortinsky KJ, et al. Interna- tional incidence and outcome of biliaryatresia[ J]. J Pediatr Gas- troenterol Nutr ,2013,56 (4) :344-354.
5Mack CL, Feldman AG, Sokol RJ. Clues to the etiology ofbile duct injury in biliary atresia[ J]. Semin Liver Dis,2012,32(4) : 307-316.
6Shneider BL, Brown MB, Haber B, et al. A multicenter study of the outcome of biliary atresia in the United States,1997 to 2000 [ J ]. J Pediatr ,2006,148 (4) :467-474.
7Hartley JL, Davenport M, Kelly DA, et al. Biliary atresia [ J ]. Lancet ,2009,374 (9702) :1704-1713.
8Alvarez F. Is biliary atresia an immune mediated disease? [ J]. J Hepatol,2013,59 (4) :648-650.
9Mack CL,Tucker RM, Sokol RJ, et al. Armed CD4 + Thl ef- fector cells and activated macrophages participate in bile duct in- jury in murine biliary atresia[ J]. Clin Immuno1,2005,115 ( 2 ) : 200-209.
10Lu BR, Brindley SM, Tucker RM, et al. Alpha-enolase autoan- tibodies cross-reactive to viral proteins in a mouse model of bili- ary atresia[ J]. Gastroenterology ,2010,139 ( 5 ) : 1753-1761.
